These days in America, a nagging cough or strange pain often comes with a quiet calculation: is seeing a doctor really worth it? Getting sick in the United States often feels like playing a ...

The global pulmonary drug delivery technology market is projected to grow at a CAGR of approximately 5% over the next five years. This growth is driven by the rising prevalence of respiratory diseases ...

Ispire Technology Inc. remains highly speculative, with the stock down ~76% since IPO and fundamentals still weak. Read more on ISPR stock here.